Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion type Assertion NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_head.
- NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion description "[In this issue of Cancer Cell, Christensen and colleagues identify THZ1, a CDK7 inhibitor, as a potential therapy for SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_provenance.
- NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion evidence source_evidence_literature NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_provenance.
- NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion SIO_000772 25490443 NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_provenance.
- NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion wasDerivedFrom befree-2016 NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_provenance.
- NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_assertion wasGeneratedBy ECO_0000203 NP1246446.RAWIzJEFBjY3NCq3L_0Lowt-dNuFHos8fZr9uexkr1HBE130_provenance.